According to a recent FMI analysis, the Global Bleeding Disorder Testing Market Demand will grow at a 7.2% CAGR from 2023 to 2033. The market is anticipated to be valued at US$ 190 billion by the end of the assessment period. As the prevalence of liver diseases, anaemia, and other blood coagulation problems rises, so will the …